Jefferies Reiterates Hold Rating on Moderna (MRNA): "cash breakeven guidance is clearer"
Tweet Send to a Friend
Jefferies analyst Andrew Tsai reiterated a Hold rating and $37.00 price target on Moderna ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
